Comparison of adjuvant therapy with tamoxifen and goserelin vs CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four year results of ABCSG trial 5. - Jakesz,R.; Hausmaninger,H.; Samonigg,H.; Kubista,E.; Depisch,E.; Fridrik,M.; Stierer,M.; Gnant,M.; Steger,G.; Kolb,R.; Jatzko,G.; Hofbauer,F.; et al. (Proc ASCO, 1999)